Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach

NCT02553915 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Overweight
Inflammation

Interventions

OTHER: Placebo
DRUG: EPA 1 g/day
DRUG: EPA 2 g/day
DRUG: EPA 4 g/day

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]